TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Methadone/therapeutic use
KW - Observational Studies as Topic
KW - Opioid-Related Disorders/drug therapy
KW - Randomized Controlled Trials as Topic
KW - opioid agonist treatment
KW - Randomization
KW - Rapid review
KW - Retention
AU - J. Klimas
AU - M. A. Hamilton
AU - L. Gorfinkel
AU - A. Adam
AU - W. Cullen
AU - E. Wood
A1 - 
AD - British Columbia Centre On Substance Use, 400-1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada. jan.klimas@ubc.ca.; Innovation Support Unit, Department of Family Practice, University of British Columbia, 3rd Floor David Strangway Building, 5950 University Boulevard, Vancouver, BC, V6T 1Z3, Canada. jan.klimas@ubc.ca.; Innovation Support Unit, Department of Family Practice, University of British Columbia, 3rd Floor David Strangway Building, 5950 University Boulevard, Vancouver, BC, V6T 1Z3, Canada.; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.; British Columbia Centre On Substance Use, 400-1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada.; School of Medicine, University College Dublin, Health Sciences Centre, Belfield, Dublin 4, Ireland.; British Columbia Centre On Substance Use, 400-1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada.; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
BT - Systematic reviews
C5 - Financing & Sustainability; Opioids & Substance Use
CP - 1
DO - 10.1186/s13643-021-01764-9
IS - 1
JF - Systematic reviews
LA - eng
M1 - Journal Article
PB - . The Author(s)
PY - 2021
SN - 2046-4053; 2046-4053
SP - 216
T1 - Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
T2 - Systematic reviews
TI - Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
U1 - Financing & Sustainability; Opioids & Substance Use
U2 - 34362464
U3 - 10.1186/s13643-021-01764-9
VL - 10
VO - 2046-4053; 2046-4053
Y1 - 2021
Y2 - Aug 6
ER -